148 related articles for article (PubMed ID: 6368445)
21. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
[TBL] [Abstract][Full Text] [Related]
22. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
[TBL] [Abstract][Full Text] [Related]
23. De-Nol in the treatment of reflux esophagitis.
Balan G; Săndulescu E; Cijevschi C; Stanciu R; Darwish R; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):67-70. PubMed ID: 2682898
[TBL] [Abstract][Full Text] [Related]
24. Present and future treatment of peptic ulcer and potential role of DE-NOL.
Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
[No Abstract] [Full Text] [Related]
25. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
[TBL] [Abstract][Full Text] [Related]
26. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer.
Lazzaroni M; Petrillo M; Bianchi Porro G
Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626
[TBL] [Abstract][Full Text] [Related]
27. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J
Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850
[No Abstract] [Full Text] [Related]
28. Efficacy of cimetidine and tri-potassium di-citrato bismuthate (De-Nol) in chronic gastric ulceration: a comparative study.
Tanner AR; Cowlishaw JL; Cowen AE; Ward M
Med J Aust; 1979 Jan; 1(1):1-2. PubMed ID: 763184
[TBL] [Abstract][Full Text] [Related]
29. Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
Lee SP
Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):359-64. PubMed ID: 7335960
[TBL] [Abstract][Full Text] [Related]
30. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
Maev IV; Samsonov AA; Golubev NN
Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841
[TBL] [Abstract][Full Text] [Related]
31. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
[TBL] [Abstract][Full Text] [Related]
32. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
[No Abstract] [Full Text] [Related]
33. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
Treiber G; Walker S; Klotz U
Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
[TBL] [Abstract][Full Text] [Related]
34. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
[TBL] [Abstract][Full Text] [Related]
35. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
[TBL] [Abstract][Full Text] [Related]
36. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
Tripathi BM; Misra NP; Dube S
J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
[No Abstract] [Full Text] [Related]
37. Cimetidine vs. placebo in prepyloric gastric ulcer therapy. Six week controlled double blind investigation without any antacid therapy.
Collen M; Stubrin S; Hanan M; Maher J; Rent M
Acta Gastroenterol Latinoam; 1980; 10(3):199-202. PubMed ID: 7013403
[TBL] [Abstract][Full Text] [Related]
38. Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
Glover SC; Cantlay JS; Weir J; Mowat NA
Dig Dis Sci; 1983 Jan; 28(1):13-7. PubMed ID: 6185289
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
40. Dose-finding clinical assay of triletide in gastric and duodenal ulceration.
Waucquez JL
Pharmatherapeutica; 1985; 4(3 Spec No):146-54. PubMed ID: 4059296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
